Yue-Fen Wang

570 total citations
26 papers, 427 citations indexed

About

Yue-Fen Wang is a scholar working on Nephrology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yue-Fen Wang has authored 26 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 8 papers in Molecular Biology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yue-Fen Wang's work include Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Yue-Fen Wang is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Renal Diseases and Glomerulopathies (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Yue-Fen Wang collaborates with scholars based in China and United States. Yue-Fen Wang's co-authors include Shengbiao Wang, Harvey A. Schenkein, J. A. Burmeister, Scott R. Diehl, Joseph V. Califano, Ateeq Ahmad, Alan P. Breau, Ji Y. Zhang, David L. Page and Roy H. Bible and has published in prestigious journals such as PLoS ONE, Scientific Reports and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Yue-Fen Wang

24 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yue-Fen Wang China 11 136 113 59 50 49 26 427
Angela N. Sheerin United Kingdom 13 237 1.7× 42 0.4× 15 0.3× 11 0.2× 18 0.4× 20 487
Haixiang Su China 12 174 1.3× 99 0.9× 12 0.2× 23 0.5× 34 0.7× 20 469
Nilgün Gürbüz Türkiye 11 165 1.2× 18 0.2× 14 0.2× 16 0.3× 45 0.9× 27 335
Renny S. Lan United States 10 255 1.9× 9 0.1× 26 0.4× 12 0.2× 20 0.4× 26 386
Yinliang Qi China 11 140 1.0× 39 0.3× 16 0.3× 8 0.2× 19 0.4× 36 351
Gábor Törő United States 11 249 1.8× 7 0.1× 20 0.3× 23 0.5× 53 1.1× 16 670
Juan Molina-Güarneros Mexico 12 152 1.1× 6 0.1× 21 0.4× 53 1.1× 42 0.9× 30 446
Przemysław Kopczyński Poland 10 164 1.2× 6 0.1× 21 0.4× 13 0.3× 47 1.0× 27 412

Countries citing papers authored by Yue-Fen Wang

Since Specialization
Citations

This map shows the geographic impact of Yue-Fen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue-Fen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue-Fen Wang more than expected).

Fields of papers citing papers by Yue-Fen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue-Fen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue-Fen Wang. The network helps show where Yue-Fen Wang may publish in the future.

Co-authorship network of co-authors of Yue-Fen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yue-Fen Wang. A scholar is included among the top collaborators of Yue-Fen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue-Fen Wang. Yue-Fen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yue-Fen, Jin Xie, Yimin Li, et al.. (2025). Serum advanced glycation end products as a putative biomarker in Type2 DKD patients’ prognosis. Frontiers in Physiology. 16. 1541198–1541198.
2.
Xie, Jin, Yimin Li, Meng Yuan, et al.. (2025). Adjusted glycated albumin is a novel indicator of glycemic control in patients with macroalbuminuria in diabetic kidney disease. Scientific Reports. 15(1). 13812–13812.
3.
Fan, Jue, Xiangrong Guo, Hui Hua, et al.. (2024). Longitudinal associations of social jetlag with obesity indicators among adolescents - Shanghai adolescent cohort. Sleep Medicine. 121. 171–178. 2 indexed citations
4.
Fan, Jue, Xiangrong Guo, Hui Hua, et al.. (2023). Rapid increases in BMI waist to height ratio during adolescence and subsequent neurobehavioral deficits. Obesity. 31(11). 2822–2833. 2 indexed citations
5.
Li, Jialin, et al.. (2023). Association between thyroid hormones and diabetic kidney disease in Chinese adults. BMC Endocrine Disorders. 23(1). 56–56. 11 indexed citations
6.
Guo, Yifan, Mengdi Wang, Yufei Liu, et al.. (2023). BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease. Chinese Medicine. 18(1). 32–32. 8 indexed citations
7.
Yu, Ting, Dongqing Xu, Jue Fan, et al.. (2023). Homework, sleep insufficiency and adolescent neurobehavioral problems: Shanghai Adolescent Cohort. Journal of Affective Disorders. 332. 273–282. 7 indexed citations
8.
9.
Gao, Yanbin, et al.. (2020). Effect of Tang-Shen-Ning decoction on podocyte epithelial-esenchymal transformation via inhibiting Wnt/β-catenin pathway in diabetic mice. Annals of Palliative Medicine. 10(12). 12921–12936. 8 indexed citations
10.
Wang, Yue-Fen, et al.. (2019). Effects of BSF on Podocyte Apoptosis via Regulating the ROS-Mediated PI3K/AKT Pathway in DN. Journal of Diabetes Research. 2019. 1–10. 27 indexed citations
11.
Zhang, Jianghua, et al.. (2019). Medicine in Future and Advantages of Integrated Chinese and Western Medicine. Chinese Journal of Integrative Medicine. 25(2). 87–90. 10 indexed citations
12.
Gao, Yanbin, et al.. (2019). Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy. Journal of Diabetes Research. 2019. 1–16. 24 indexed citations
13.
14.
Wang, Yue-Fen, et al.. (2012). The effect of hydrochloride pioglitazone on urinary 8-hydroxy -deoxyguanosine excretion in type 2 diabetics. Journal of Diabetes and its Complications. 27(1). 75–77. 11 indexed citations
15.
Ahmad, Ateeq, Yue-Fen Wang, & Imran Ahmad. (2005). Separation of Liposome-Entrapped Mitoxantrone from Nonliposomal Mitoxantrone in Plasma: Pharmacokinetics in Mice. Methods in enzymology on CD-ROM/Methods in enzymology. 391. 176–185. 22 indexed citations
16.
Khan, Sumsullah, Ateeq Ahmad, Wei Guo, et al.. (2004). A simple and sensitive LC/MS/MS assay for 7-ethyl-10-hydroxycamptothecin (SN-38) in mouse plasma and tissues: application to pharmacokinetic study of liposome entrapped SN-38 (LE-SN38). Journal of Pharmaceutical and Biomedical Analysis. 37(1). 135–142. 35 indexed citations
17.
Zhang, Ji Y., et al.. (2004). Disposition and Pharmacokinetics of L-N6-(1-Iminoethyl)Lysine-5-Tetrazole-Amide, a Selective iNOS Inhibitor, in Rats. Journal of Pharmaceutical Sciences. 93(5). 1229–1240. 7 indexed citations
18.
Zhang, Ji Y., et al.. (2003). Pharmacokinetics and Metabolism of a COX-2 Inhibitor, Valdecoxib, in Mice. Drug Metabolism and Disposition. 31(4). 491–501. 34 indexed citations
19.
Wamil, Barbara D., Gary B. Thurman, Håkan Sundell, et al.. (1997). Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial. Journal of Cancer Research and Clinical Oncology. 123(3). 173–179. 5 indexed citations
20.
Thurman, Gary B., Gerald E. York, Yue-Fen Wang, et al.. (1994). Effects of group BStreptococcus toxin on long-term survival of mice bearing transplanted Madison lung tumors. Journal of Cancer Research and Clinical Oncology. 120(8). 479–484. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angela N. Sheerin Breakdown of academic impact, for papers by Haixiang Su Breakdown of academic impact, for papers by Nilgün Gürbüz Breakdown of academic impact, for papers by Renny S. Lan Breakdown of academic impact, for papers by Yinliang Qi Breakdown of academic impact, for papers by Gábor Törő Breakdown of academic impact, for papers by Juan Molina-Güarneros Breakdown of academic impact, for papers by Przemysław Kopczyński
Rankless by CCL
2026